The CRA II is responsible for monitoring Phase I–IV clinical trials to ensure compliance with protocols, GCP/ICH guidelines, and regulatory requirements.
Base: $84,000.00 - $170,900.00; Bonus/Equity: Not specified; Benefits: health and wellness and/or other benefits
Must-have
Nice-to-have
Not specified